For patients with a confirmed annular tear driving their disc pain, intra-annular fibrin injection delivers more durable, structural relief than PRP. PRP works best for facet inflammation and early disc pain without a structural tear. The right treatment depends on the exact pain source — a clinical evaluation is the only way to know which fits your case.
The Short Answer: Which One Wins?
Both treatments are minimally invasive biologics — no incisions, no fusion hardware. But they treat different problems. PRP is a healing accelerant. The fibrin-based disc treatment is a structural repair. Choosing between them starts with understanding what is actually causing your pain.
| Decision Factor | PRP (Platelet-Rich Plasma) | Intra-Annular Fibrin Injection |
|---|---|---|
| Primary mechanism | Platelets and growth factors stimulate local healing | FDA-approved fibrin sealant repairs annular tears and supports disc matrix |
| Best target pathology | Facet inflammation, mild discogenic pain, peri-spinal soft tissue | Painful annular tears, discogenic low back pain, post-surgical disc pain |
| Reported pain relief | ~47% achieve ≥50% relief at 6 months (outcomes meta-analysis) | VAS 72.4 mm at baseline to 33.0 mm at 104 weeks (peer-reviewed cohort data) |
| Durability | Months to roughly 1 year; variable past 12 months | 2+ years documented in long-term follow-up cohorts |
| Failed back surgery populations | Limited evidence base | 80% of failed back surgery patients reported positive outcomes; individual outcomes vary |
| Recovery | 1–3 days of soreness; return to light activity quickly | Several days of activity modification; return to normal life within 1–2 weeks |
| Repeatability | Administered as a series of injections | Designed as a single targeted procedure |
How Do These Two Treatments Work Differently?
PRP (platelet-rich plasma) is prepared from the patient’s own blood. Centrifugation isolates platelets and the growth factors they carry. When injected near a painful joint or peridiscal space, those signals recruit repair cells and reduce local inflammation. PRP works best as a healing accelerant for tissues that retain some repair capacity.
The fibrin-based disc treatment is a structural repair. An FDA-approved fibrin sealant is delivered directly into the annular tear under fluoroscopic guidance. The fibrin polymerizes inside the tear, supports collagen ingrowth, and reduces the inflammatory leak that drives discogenic pain. For a comparison of the fibrin procedure vs. surgery, see our guide on fibrin disc treatment vs. spinal fusion.
Which Treatment Has Stronger Outcome Data?
The published evidence favors the fibrin-based disc treatment for patients with confirmed annular pathology — particularly those with chronic pain and prior treatment failures.
Among the most-tracked PRP results, approximately 47% of patients achieved 50% or greater pain relief at 6 months (outcomes meta-analysis). Durability past 12 months is variable, and repeat injections are common. Individual outcomes vary.
The fibrin procedure shows more durable numbers. Published cohort data report a VAS reduction from 72.4 mm at baseline to 33.0 mm at 104 weeks, and 70% patient satisfaction at 2+ year follow-up. In failed back surgery patients, 80% reported positive outcomes after the fibrin procedure. For a broader comparison of biologics vs. epidural steroids, see our guide on lumbar epidural steroid injection vs. regenerative biologics.
Expert Take
The Valor team sees patients regularly who have completed multiple rounds of PRP and are still living with the same disc pain. That is not a failure of the patient — it is a mismatch between treatment and pathology. PRP delivers real benefit when the pain driver is inflammation or early soft-tissue degeneration. When a structural annular tear is driving the pain, addressing the biochemical environment around it does not seal it. The diagnostic question is exactly what a thorough evaluation is designed to answer first.
Who Is the Right Candidate for Each Procedure?
Candidacy depends on the specific pain source identified through imaging and clinical evaluation — not a symptom checklist. A clinical evaluation is the only way to know which option fits your case.
PRP suits patients with imaging-confirmed facet arthropathy, mild discogenic pain without a confirmed annular tear, or peri-spinal soft tissue pain.
The fibrin-based disc treatment is built for patients with discogenic pain driven by a confirmed annular tear, persistent pain following a herniation, or pain that has not responded to conservative care and steroid injections. It is also a primary option for patients who have been told fusion is the next step. Learn more about failed back surgery syndrome and what comes next.
What Does Recovery Look Like for Each?
Neither procedure requires hospitalization or the weeks-long restrictions associated with spinal fusion.
After PRP, most patients experience 1–3 days of localized soreness. Return to light activity is quick. After the fibrin procedure, patients modify activity for several days, with most returning to normal life within 1–2 weeks. No incisions, no overnight stay. See our guide on why patients choose regenerative spine care over traditional operations.
How Do These Options Compare to Surgery?
Both are non-surgical — no incisions, no general anesthesia, no fusion hardware. Back surgery carries roughly a 40% rate of not achieving the patient’s desired outcome (peer-reviewed FBSS literature). The fibrin procedure addresses the annular pathology that drives discogenic pain — the same pathology that a fusion addresses by immobilizing the segment rather than repairing it. See our full breakdown of biologic disc repair as a modern fusion alternative.
Frequently Asked Questions
Is PRP or the fibrin procedure better for a herniated disc?
For a herniated disc with a confirmed annular tear, the fibrin-based disc treatment targets the structural source. PRP addresses inflammation but does not seal the tear. A clinical evaluation determines which approach fits.
How long does pain relief last after each procedure?
PRP durability is roughly months to one year, with variability past 12 months. The fibrin procedure shows 2+ year durability in long-term cohorts, with 70% patient satisfaction at that mark. Individual outcomes vary.
Can I have the fibrin procedure if I already had back surgery?
The procedure has been used in failed back surgery populations, with 80% of tracked patients reporting positive outcomes. Individual outcomes vary. A clinical evaluation determines candidacy.
Is the fibrin sealant FDA-approved?
The fibrin sealant used in the procedure is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient.
How many of these procedures have been performed?
More than 13,000 procedures have been performed nationally. Among over 7,000 with long-term follow-up, the tracked success rate is 83% — a population-level statistic; individual outcomes vary.
How do I know which option is right for my case?
A clinical evaluation — including review of existing MRI findings — is the only way to know for certain. The Valor team offers a no-cost MRI review as a starting point. Explore the full range of non-surgical disc pain treatments available.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
